The News Review:
- 23andMe And The Parkinson’s Institute Announce Initiative To…
- Top Academic Medical Centers Research Institutions and Partners…
- Researchers Find Adding Epratuzumab to Standard Therapy
- New Treatment Implications for varian Cancer Unveiled
- Xceed Molecular Features Ziplex(R) Automated Gene-Expression System…
- W.Va. offers fitness program to people with arthritis
23andMe And The Parkinson’s Institute Announce Initiative To…
Medical News Today – Medical News Today (press release) – May 16, 2008
- Patients’ risk factor and clinical data collected through the newly developed and validated web-based tools will then be merged with their genetic data to conduct research on Parkinson’s disease. - New surveys will be developed and administered to the growing cohort of patients generating new risk factor and clinical data for comparison with the existing genetic data. - Through the deployment of an innovative approach to clinical research information gathering utilizing web-based tools the initiative will help to expand the involvement of Parkinson’s disease patients in clinical research and increase the frequency and uniformity of patient data collection. The existing model for collecting patient information does not effectively identify genetic and environmental causes of Parkinson’s disease or novel transformative therapies for Parkinson’s disease patients and requires: multiple patient visits to a limited number of skilled clinical sites; time and distant prohibitive visits; costly and labor-intensive on-site efforts. Furthermore the existing model for clinical research does not have access to a large enough pool of study participants to identify the cause and early indicators of Parkinson’s disease. “This partnership represents the basis for ‘Research 2. 0′ a new research architecture that web-enables validated diagnostic procedures and combines them with genetic profiles of Parkinson’s patients” said Linda Avey co-founder of 23andMe… - Through the deployment of an innovative approach to clinical research information gathering utilizing web-based tools the initiative will help to expand the involvement of Parkinson’s disease patients in clinical research and increase the frequency and uniformity of patient data collection. The existing model for collecting patient information does not effectively identify genetic and environmental causes of Parkinson’s disease or novel transformative therapies for Parkinson’s disease patients and requires: multiple patient visits to a limited number of skilled clinical sites; time and distant prohibitive visits; costly and labor-intensive on-site efforts. Furthermore the existing model for clinical research does not have access to a large enough pool of study participants to identify the cause and early indicators of Parkinson’s disease. “This partnership represents the basis for ‘Research 2. 0′ a new research architecture that web-enables validated diagnostic procedures and combines them with genetic profiles of Parkinson’s patients” said Linda Avey co-founder of 23andMe. “By building a social network for the Parkinson’s disease community and combining it with the world-class expertise of Parkinson’s Institute researchers we hope to establish an entirely new paradigm for how genetic research is conducted that actively involves the patient. ” Katie Hood CE of The Michael J.
Top Academic Medical Centers Research Institutions and Partners…
Earthtimes – May 16, 2008
customers receive over 30 percent of extramural clinicalresearch funding from the National Institutes of Health among the 100 largestsuch recipients — the largest such share among clinical trial managementsystem software vendors. The National Cancer Institute grants approximately40 percent of its extramural funding to such Velos customers also the largestsuch share. The Velos eResearch customer base includes 21 top 25* U.
Researchers Find Adding Epratuzumab to Standard Therapy
Newswise – Newswise (press release) – May 16, 2008
both of Cancer Center of Kansas PA Wichita. NCCTG is a national clinical research group sponsored by the National Cancer Institute. Its research and administration are based at Mayo Clinic. NCCTG consists of a network of cancer specialists at community clinics hospitals and medical centers in the United States Canada and Mexico. The group is dedicated to bringing clinical trials with promising new cancer therapies to communities where patients live. American Society of Clinical ncology abstract number: 8500© 2008 Newswise.
New Treatment Implications for varian Cancer Unveiled
Newswise – Newswise (press release) – May 16, 2008
; and research teaching specialist Neelakandan Muthukumaran ? is planning Phase II studies for patients with ovarian and endometrial cancers in the future. Rodriguez will be among the more than 30000 cancer specialists from around the globe who will showcase advances in clinical research at the annual ASC meeting. About The Cancer Institute of New JerseyThe Cancer Institute of New Jersey is the state?s first and only National Cancer Institute-designated Comprehensive Cancer Center and is dedicated to improving the prevention detection treatment and care of patients with cancer. CINJ?s physician-scientists engage in translational research transforming their laboratory discoveries into clinical practice quite literally bringing research to life. The Cancer Institute of New Jersey is a center of excellence of UMDNJ-Robert Wood Johnson Medical School. To support CINJ please call the Cancer Institute of New Jersey Foundation at 1-888-333-CINJ.
Xceed Molecular Features Ziplex(R) Automated Gene-Expression System…
Earthtimes – May 16, 2008
"Results from traditional technology are also prone to unacceptable levels ofvariability to meet the rigorous performance and quality-control needs of theclinical-diagnostic laboratory. Xceed designed the Ziplex System with turnkeyfunctionality and significant advances in automation array format fluidicsparallel sample processing and analytics to minimize complexity userinteraction and variability between users and sites. ur goal: to makeroutine molecular diagnostics easy reproducible and affordable to serve theneeds of both clinical research and clinical-diagnostic settings — whichdemand that results remain consistent even when samples are run by differentpeople at different times or in different sites. "Luncheon WorkshopXceed is hosting a luncheon workshop from 12 to 1:30 pm on Wednesday May21 2008 in the Howe Room of the Loews Philadelphia Hotel. Ziplex System for Focused Content Multiplexed Gene-Expression Analysis –Introduction and Study ResultsDavid Englert Ph. VP Technology Development Xceed MolecularToronto.
W.Va. offers fitness program to people with arthritis
Daily Mail – Charleston – May 16, 2008
The Department of Health and Human Resources plans to offer a free six-month exercise program called EnhancedFitness at 11 sites in eight counties. WVU will train instructors for the program next week in Charleston. Dina Jones director of clinical research in the WVU School of Medicine's Department of rthopedics will study the program and how it can help people with arthritis. EnhancedFitness focuses on increasing strength improving balance and increasing energy levels. The DHHR says 37 percent of West Virginia adults have been diagnosed with arthritis the highest rate in the nation. West Virginia University and the state want to help people with arthritis have active lifestyles. The Department of Health and Human Resources plans to offer a free six-month exercise program called EnhancedFitness at 11 sites in eight counties.
